New Products and Industry Press Releases

October 2014 - Posts

BIVI Announces Prascend® Horse Owner Contest Winners

  • 2 Oct 2014

Prascend® (pergolide mesylate) has been available to U.S. veterinarians and horse owners for nearly three years as a treatment option for horses suffering from Pituitary Pars Intermedia Dysfunction (PPID), formerly known as equine Cushing's disease. In an effort to raise awareness of the disease and share treatment success stories, Boehringer Ingelheim Vetmedica, Inc. (BIVI), manufacturers of PRASCEND, recently hosted a testimonial contest.... Read More

About This Blog

Announcements concerning the horse industry.